Assessment of C-reactive Protein and C3 as Inflammatory Markers of Insulin Resistance in Women with Polycystic Ovary Syndrome: A Case-Control Study
Open Access
- 1 October 2013
- journal article
- Vol. 14 (4) , 197-201
Abstract
Polycystic ovary syndrome (PCOS), a common endocrine disorder, is associated with infertility, menstrual dysfunction, hirsutism and frequent miscarriages. Insulin resistance, as a major cause of PCOS, represents a disorder with increase in inflammatory markers and risk of type 2 diabetes. We aimed to investigate whether inflammatory markers, including C-reactive protein and C3 (Complement), are related and altered in polycystic ovary syndrome. A case-control study including forty-two women diagnosed with PCOS, according to Rotterdam criteria, and forty-two healthy controls, matched for body mass index (BMI) and age, was conducted in 2012. C-Reactive protein (CRP) and C3 were assessed as possible determinants of the homeostasis model assessment (HOMA) index. Independent-sample t-test was used to compare the means of the groups in age, BMI, C3, FBS and BS 2hpp (2 hr postprandial glucose) and for CRP, Fasting Insulin and 2 hr Plasma Insulin and HOMA index. Mann-Whitney test and Pearson correlation were used for analyzing the data. The p<0.05 was considered as statistically significant. Levels of plasma CRP (p=0.039), 2 hr pp (p=0.045), Fasting Insulin (p=0.002), 2 hr Plasma Insulin (p=0.002) and HOMA index (p=0.002) were significantly higher in PCOS patients. But C3 was not significantly higher in cases (p=0.885). There was no significant correlation between C3 and CRP with HOMA index. CRP increased significantly in patients with PCOS and was associated with insulin resistance, the most probable cause of PCOS. However, such an association was not found in C3.Keywords
This publication has 21 references indexed in Scilit:
- Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.2013
- Contemporary genetic technologies and female reproductionHuman Reproduction Update, 2011
- Serum complement C3 has a stronger association with insulin resistance than high-sensitivity C-reactive protein in women with polycystic ovary syndromeFertility and Sterility, 2011
- Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndromeGynecological Endocrinology, 2007
- Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metforminHuman Reproduction, 2006
- C-reactive protein is elevated in obese patients with the metabolic syndromeDiabetes Research and Clinical Practice, 2006
- The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic menAtherosclerosis, 2005
- The importance of insulin resistance in polycystic ovary syndromeFertility and Sterility, 2003
- Association between C-reactive protein and features of the metabolic syndrome: a population-based study.Diabetes Care, 2000
- Dyslipidaemia is associated with insulin resistance in women with polycystic ovariesClinical Endocrinology, 1996